Duramycin is a 19-amino-acid tetracyclic lantibiotic closely related to cinnamycin (Ro09-0198), which is known to bind phosphatidylethanolamine (PE). The lipid specificity of duramycin was not established. The present study indicates that both duramycin and cinnamycin exclusively bind to ethanolamine phospholipids (PE and ethanolamine plasmalogen). Model membrane study indicates that the binding of duramycin and cinnamycin to PE-containing liposomes is dependent on membrane curvature, i.e., the lantibiotics bind small vesicles more efficiently than large liposomes. The binding of the lantibiotics to multilamellar liposomes induces tubulation of membranes, as revealed by electron microscopy and small-angle x-ray scattering. These results suggest that both duramycin and cinnamycin promote their binding to the PE-containing membrane by deforming membrane curvature.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948045PMC
http://dx.doi.org/10.1529/biophysj.106.101584DOI Listing

Publication Analysis

Top Keywords

duramycin cinnamycin
16
ethanolamine phospholipids
8
study indicates
8
membrane curvature
8
duramycin
6
cinnamycin
5
curvature-dependent recognition
4
recognition ethanolamine
4
phospholipids duramycin
4
cinnamycin duramycin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!